Carmike Cinemas price target raised to $37 from $30 at Maxim Maxim raised its price target for Carmike Cinemas shares to $37 ahead of the company's Q4 results and maintains a Buy rating on the stock. The firm expects the company's move into higher end theaters and the success of Gravity in 3D should drive growth.
Carmike remains undervalued relative to peers, says B. Riley B. Riley analyst Eric Wold says Oasis Management's letter to Carmike Cinemas, as reported last night by Reuters, highlights a number of the arguments he's been making. Wold continues to view Carmike as a "meaningfully undervalued" theater chain with the potential for a dividend. He reiterates a Buy rating on the stock with a $32 price target.